🆕️⚡️Retrospective study🔴 #IJAA
Dalbavancin versus standard of care for Staphylococcus aureus bacteremia in patients unable to receive outpatient parenteral antimicrobial therapy
#DOTS#IDTwitter#OPAT
https://t.co/dNQAPp7fMi
Check out our virtual poster @IDWeek2022 showing dalbavancin may be more favorable for certain pts w/ S aureus bacteremia to avoid placement if unsuitable for OPAT. Great work by fmr PGY1 Dillon Frazier! #IDWeek2022@jwagsIDPharmD @PotOnMyHead @andhen25